Large-scale testing (Phase 3)Study completedNCT01183780What this trial is testingA Study in Second Line Metastatic Colorectal CancerWho this might be right forColorectal Cancer Eli Lilly and Company 1,072
Testing effectiveness (Phase 2)Ended earlyNCT00642603What this trial is testingXeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerWho this might be right forColorectal Cancer Hoffmann-La Roche 41
Testing effectiveness (Phase 2)Ended earlyNCT02568046What this trial is testingSym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer PatientsWho this might be right forMetastatic Colorectal Cancer Symphogen A/S 10
Large-scale testing (Phase 3)Looking for participantsNCT05768503What this trial is testingComparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRCWho this might be right forMetastatic Microsatellite-stable Colorectal Cancer Sun Yat-sen University 176
Testing effectiveness (Phase 2)Study completedNCT00615056What this trial is testingA Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line RegimenWho this might be right forColorectal Neoplasms Pfizer 171
Large-scale testing (Phase 3)UnknownNCT03950154What this trial is testingStudy of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal CancerWho this might be right forColorectal Cancer Tianjin Medical University Cancer Institute and Hospital 198
Not applicableUnknownNCT02842294What this trial is testingCohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal CancerQuality of Life Centre Hospitalier Universitaire de Besancon 320
Testing effectiveness (Phase 2)Study completedNCT00251485What this trial is testingA Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal CancerWho this might be right forColorectal Cancer Veeda Oncology 82
Testing effectiveness (Phase 2)WithdrawnNCT03222089What this trial is testingPhase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRCWho this might be right forMetastatic Colorectal Cancer Fujian Cancer Hospital
Testing effectiveness (Phase 2)Study completedNCT01442935What this trial is testingChemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic MetastasesWho this might be right forColorectal Cancer UNICANCER 256
Testing effectiveness (Phase 2)UnknownNCT01832948What this trial is testingEndostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Zhejiang Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01442649What this trial is testingEfficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With BevacizumabWho this might be right forColorectal Cancer UNICANCER 133
Large-scale testing (Phase 3)Study completedNCT00145314What this trial is testingFLOX in Combination With Cetuximab in First-line Treatment of Colorectal CancerWho this might be right forMetastatic Colorectal Cancer The Nordic Colorectal Cancer Biomodulation Group 571
Testing effectiveness (Phase 2)UnknownNCT06491355What this trial is testingFirst-Line Treatment Induced With mFOLFOX6 and HLX04 Regimen, Following Combined With Serplulimab in MSS Initially Unresectable Metastatic Colorectal CancerWho this might be right forEfficacy, SelfSafety IssuesColo-rectal Cancer Sir Run Run Shaw Hospital 72
Large-scale testing (Phase 3)UnknownNCT00182715What this trial is testingCombination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerWho this might be right forColorectal Cancer Velindre NHS Trust 2,421
Large-scale testing (Phase 3)Study completedNCT01169558What this trial is testingBevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.Who this might be right forColorectal Cancer Hoffmann-La Roche 168
Large-scale testing (Phase 3)Study completedNCT00202774What this trial is testingSafety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal CancerWho this might be right forColorectal Cancer Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 348
Large-scale testing (Phase 3)Active Not RecruitingNCT04793958What this trial is testingPhase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)Who this might be right forAdvanced Colorectal CancerMetastatic Colorectal Cancer Mirati Therapeutics Inc. 461
Testing effectiveness (Phase 2)Study completedNCT00541125What this trial is testingG-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal CancerWho this might be right forColorectal Cancer Federation Francophone de Cancerologie Digestive 20
Large-scale testing (Phase 3)UnknownNCT02942706What this trial is testingCetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRCWho this might be right forColorectal Cancer Ruijin Hospital 200